The Interleukin-6 −147 G/C Polymorphism Is Associated with Increased Risk of Coronary Artery Disease in Young South African Indian Men
- 1 June 2013
- journal article
- research article
- Published by SAGE Publications in Metabolic Syndrome and Related Disorders
- Vol. 11 (3) , 205-209
Abstract
Background: Interleukin-6 (IL-6) is a proinflammatory cytokine involved in the pathogenesis of chronic inflammatory diseases such as coronary artery disease (CAD). The −174 IL-6 G/C promoter polymorphism influences mRNA levels and protein expression and is implicated in CAD. The Indian population in South Africa, unlike the black community, has a high prevalence of premature CAD. This polymorphism has not been fully explored in this population. The present study assessed the −174 IL-6 G/C polymorphism in young Indian patients with angiographically documented CAD and compared them with age- and gender-matched Indian and black control subjects. Methods: Polymorphic variants were assessed by polymerase chain reaction–restriction fragment length polymorphism, and IL-6 levels were measured using enzyme-linked immunosorbent assay (ELISA). Results: The −174 IL-6 C allele was found with a higher frequency (23%) in the total Indian group compared to 2% in the black participants [ P P P =0.043, OR=0.47 95% CI 0.23–0.95). Levels of IL-6 in circulation were higher in black controls (6.62±0.63 pg/mL) compared to Indian controls (2.51±0.57 pg/mL) and CAD patients (1.46±0.36 pg/mL) ( P P =0.0001). Conclusion: The presence of the IL-6 −174 G allele influences levels of IL-6 and increases the risk of CAD in South African Indians.Keywords
This publication has 21 references indexed in Scilit:
- Effects of 174 G/C polymorphism in the promoter region of the interleukin-6 gene on plasma IL-6 levels and muscle strength in elderly womenBrazilian Journal of Medical and Biological Research, 2011
- The −174 G/C Polymorphism in Interleukin-6 (IL-6) Promoter Region is Associated with Serum IL-6 and Carcinoembryonic Antigen Levels in Patients with Colorectal Cancers in TaiwanJournal of Clinical Immunology, 2009
- Interleukin-6 −174 promoter polymorphism does not influence IL-6 production after LPS and IL-1β stimulation in human umbilical cord vein endothelial cellsCytokine, 2007
- IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the uglyKidney International, 2005
- Usefulness of high‐sensitivity IL‐6 measurement for clinical characterization of patients with coronary artery diseaseJournal of Clinical Laboratory Analysis, 2005
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- The −174 C/G locus affects in vitro/in vivo IL-6 production during agingExperimental Gerontology, 2002
- Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?Atherosclerosis, 2000
- The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.Journal of Clinical Investigation, 1998
- On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion.Molecular and Cellular Biology, 1990